Skip to content

Gestational diabetes and vitamin D

The Impact of Vitamin D Supplementation in Gestational Diabetes Cases on Post-Partum Glucose Tolerance and Insulin Resistance: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012101611144N1
Enrollment
110
Registered
2012-10-24
Start date
2012-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes. Diabetes mellitus arising in pregnancy

Interventions

Intervention 1: Control group: blood glucose, vitamin D and Ca measurement. Intervention 2: vitamin D, pearl 50000 IU, at first taking 4 pearls in 2days following(2 for each day) and then weekly. In
Treatment - Drugs
Control group: blood glucose, vitamin D and Ca measurement.
vitamin D, pearl 50000 IU, at first taking 4 pearls in 2days following(2 for each day) and then weekly. In the cases more than 30 weeks, weekly 2 pearls

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor
Added at 2014-04-13: :ARKRAY company
Collaborator

Eligibility

Sex/Gender
Female
Age
16 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: gestattional diabetes, singleton pregnancies , vitamin D deficient women older than 16 who filled the patient's informed consent. Exclusion criteria: 1- women with overt diabetes. 2- fat malabsorbtion 3- vitamin D injection or taking vitamin D pearls with high dose( 6 or more pearls of 50000 IU viamin D) in last 3 months. 4- hypothyroidism or hyperthyroidism 5- hypertension. 6- unwiliingness to fill the testiomonial. 7- not using the pearls

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Glucose tolerance test. Timepoint: 6-12 weeks after delivery. Method of measurement: blood glucose level.

Secondary

MeasureTime frame
Insulin resistance. Timepoint: 6-12 weeks after delivery. Method of measurement: HOMA-IR calculation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Piri

Zanjan University of Medical Sciences

zahra.piri@gmail.com; zahra.piri@rocketmail.com+98 24 1727 0714

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026